These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24602603)
1. Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate! Honoré PM; Jacobs R; De Regt J; Van Gorp V; De Waele E; Spapen HD Crit Care; 2014 Feb; 18(2):412. PubMed ID: 24602603 [No Abstract] [Full Text] [Related]
2. Dose of colistin: a work in progress? Rocco M; Montini L; De Pascale G; Antonelli M Crit Care; 2015 Feb; 19(1):65. PubMed ID: 25887411 [No Abstract] [Full Text] [Related]
3. Higher colistin dose during continuous renal replacement therapy: look before leaping! Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD Crit Care; 2015 Jun; 19(1):235. PubMed ID: 26051786 [No Abstract] [Full Text] [Related]
4. Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use. Daikos GL; Skiada A; Pavleas J; Vafiadi C; Salatas K; Tofas P; Tzanetou K; Markogiannakis A; Thomopoulos G; Vafiadi I; Petrikkos G J Chemother; 2010 Jun; 22(3):175-8. PubMed ID: 20566422 [TBL] [Abstract][Full Text] [Related]
8. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Hamer DH Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263 [TBL] [Abstract][Full Text] [Related]
9. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867 [TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa. Naesens R; Vlieghe E; Verbrugghe W; Jorens P; Ieven M BMC Infect Dis; 2011 Nov; 11():317. PubMed ID: 22085766 [TBL] [Abstract][Full Text] [Related]
11. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Mohamed AF; Karaiskos I; Plachouras D; Karvanen M; Pontikis K; Jansson B; Papadomichelakis E; Antoniadou A; Giamarellou H; Armaganidis A; Cars O; Friberg LE Antimicrob Agents Chemother; 2012 Aug; 56(8):4241-9. PubMed ID: 22615285 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [TBL] [Abstract][Full Text] [Related]
13. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093 [TBL] [Abstract][Full Text] [Related]
15. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis. Horianopoulou M; Lambropoulos S; Papafragas E; Falagas ME J Chemother; 2005 Oct; 17(5):536-8. PubMed ID: 16323443 [TBL] [Abstract][Full Text] [Related]
16. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Hachem RY; Chemaly RF; Ahmar CA; Jiang Y; Boktour MR; Rjaili GA; Bodey GP; Raad II Antimicrob Agents Chemother; 2007 Jun; 51(6):1905-11. PubMed ID: 17387153 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model. Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497 [TBL] [Abstract][Full Text] [Related]
18. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Falagas ME; Kasiakou SK; Tsiodras S; Michalopoulos A Clin Med Res; 2006 Jun; 4(2):138-46. PubMed ID: 16809407 [TBL] [Abstract][Full Text] [Related]
19. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia. Falagas ME; Kasiakou SK; Michalopoulos A J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070 [No Abstract] [Full Text] [Related]
20. Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: pressing need for validation clinical trials. Safdar A Intensive Care Med; 2010 Jul; 36(7):1110-1. PubMed ID: 20397005 [No Abstract] [Full Text] [Related] [Next] [New Search]